High incidence of chest malignancy detected by FDG PET in patients suspected of recurrent squamous cell carcinoma of the upper aerodigestive tract

Journal of Computer Assisted Tomography

Volumn 28, Issue 5, 2004, Pages 704-709

  Perlow, Alain ^a   Bui, Chuong ^a   Shreve, Paul ^a   Sundgren, Pia C ^a   Teknos, Theodoros N ^a   Mukherji, Suresh K ^a,b  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b Department of Radiology B2B311 0030 ^*  (United States)

Author keywords

Adults; Clinical; FDG, PET, head and neck cancer

Indexed keywords

COMPUTERIZED TOMOGRAPHY; NUCLEAR MEDICINE; PATHOLOGY; PATIENT TREATMENT; TUMORS;

ADULT; AVERAGE AGES; CLINICAL; FDG PET; FDG, PET, HEAD AND NECK CANCER; HEAD-AND-NECK CANCER; HIGH INCIDENCE; SQUAMOUS CELL CARCINOMA; STAGE III; UPPER AERODIGESTIVE TRACTS;

DISEASES;

FLUORODEOXYGLUCOSE F 18;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER INCIDENCE; CANCER RECURRENCE; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ERROR; DIGESTIVE SYSTEM CANCER; FEMALE; HEAD AND NECK CANCER; HIGH RISK PATIENT; HUMAN; LUNG METASTASIS; MALE; METASTASIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; THORAX RADIOGRAPHY; THORAX TUMOR;

EID: 4444310934     PISSN: 03638715     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rct.0000135279.71388.f9     Document Type: Article

References (17)

1. Vokes EV, Ralph RW, Scott ML, et al. Head and neck cancer. N Engl J Med. 1993;328:184-194.
2. Keyes JW Jr, Chen MYM, Watson NE Jr, et al. FDG Pet evaluation of head and neck cancer: value of imaging of the thorax. Head Neck. 2000;22:105-110.
3. Bar Shalom R, Valdivia AY, Blaufox DM. Pet imaging in oncology. Semin Nucl Med. 2000;30:150-185.
4. Kitagawa Y, Nishizawa S, Sano K, et al. Whole-body 18F-fluorodeoxyglucose positron emission tomography in patients with head and neck cancer. Oral Surg Oral Med Oral Pathol. 2002;93:202-207.
5. Fischbein NJ, Aassar SO, Caputo GR, et al. Clinical utility of positron tomography with F-fluorodeoxyglucose in detecting residual/recurrent squamous cell carcinoma of the head and neck. AJNR Am J Neuroradiol. 1998;19:1189-1196.
6. Teknos TN, Eben RL, Lee D, et al. Positron emission tomography in the evaluation of stage III and IV head and neck cancer. Head Neck. 2001;23:1056-1060.
7. Wax MK, Myers LL, Gabalski EC, et al. Positron emission tomography in the evaluation of synchronous lung lesions in patients with untreated head and neck cancer. Arch Otolaryngol Head Neck Surg. 2002;128:703-707.
8. Terhard CH, Bongers V, Van Rijk PP, et al. F-18 fluoro-deoxy-glucose positron-emission tomography scanning in detection of local recurrence after radiotherapy for laryngeal/pharyngeal cancer. Head Neck. 2001;23:933-941.
9. Stokkel MPM, Terhaard CHJ, Hordijk GJ, et al. The detection of local recurrent head and neck cancer with fluorine-18 fluorodeoxyglucose dual-head positron emission tomography. Eur J Nucl Med. 1999;26:767-773.
10. International Union Against Cancer (UICC). TNM Classification of Malignant Tumours. 5th ed. Geneva, Switzerland: UICC, New York: Wiley-Liss Inc.; 1997.
11. Graham MM. Is quantitation necessary for oncological PET studies? Against. Eur J Nucl Med. 2002;29:135-138.
12. Keys JW Jr. SUV: standard uptake or silly useless value? J Nucl Med. 1995;36:1836-1839.
13. Kresnik E, Mikosch P, Gallowitsch HJ, et al. Evaluation of head and neck cancer with 18F-FDG PET: a comparison with conventional methods. Eur J Nucl Med. 2001;28:816-821.
14. Quekel LG, Kessels AG, Goei R, et al. Detection of lung cancer on the chest radiograph: a study on observer performance. Eur J Radiol. 2001;39:111-116.
15. Cook GJ. The clinical use of PET-where are we now? Br J Radiol. 2001;74:399-401.
16. Hollenbeak CS, Lowe VJ, Stack BC Jr. The cost-effectiveness of fluorodeoxyglucose 18-F positron emission tomography in the NO neck. Cancer. 2001;92:2341-2348.
17. 18F-fluorodeoxyglucose PET for the detection of recurrent laryngeal cancer. Cancer Biother Radiopharm. 2002;3:303-306.